Furthermore, 43 transcripts that showed decreases in the NASH gene signature (29) were increased in HFD+AC261066/HFD, including Fgfr1, Foxo3, and Igfbp2 (Fig. S7 and Table S6). This evidence concerns the gene IGFBP2 and metabolic dysfunction-associated steatohepatitis.